Sensitivity analyses applying overlapping weights yielded similar results to our main analysis (Supplemental Table S6), with a HR for AKI of 0.89 [95% CI 0.66–1.20] among SGLT2i users compared to DPP-4i, and 0.79 [95% CI 0.57–1.09] compared to GLP1-RA. The gene discussed is GLP1R; the disease is acute kidney injury.